Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer.
Adult
Age Factors
Aged
Aged, 80 and over
Algorithms
Biomarkers, Tumor
/ genetics
Breast Neoplasms
/ metabolism
Computer Simulation
Female
Humans
Machine Learning
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
/ metabolism
Neoplasm Staging
Predictive Value of Tests
Survival Rate
Tumor Burden
Young Adult
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
entrez:
28
3
2020
pubmed:
28
3
2020
medline:
31
10
2020
Statut:
ppublish
Résumé
For patients with early-stage breast cancer, predicting the risk of metastatic relapse is of crucial importance. Existing predictive models rely on agnostic survival analysis statistical tools (eg, Cox regression). Here we define and evaluate the predictive ability of a mechanistic model for time to distant metastatic relapse. The data we used for our model consisted of 642 patients with 21 clinicopathologic variables. A mechanistic model was developed on the basis of two intrinsic mechanisms of metastatic progression: growth (parameter α) and dissemination (parameter μ). Population statistical distributions of the parameters were inferred using mixed-effects modeling. A random survival forest analysis was used to select a minimal set of five covariates with the best predictive power. These were further considered to individually predict the model parameters by using a backward selection approach. Predictive performances were compared with classic Cox regression and machine learning algorithms. The mechanistic model was able to accurately fit the data. Covariate analysis revealed statistically significant association of By providing informative estimates of the invisible metastatic burden at the time of diagnosis and forward simulations of metastatic growth, the proposed model could be used as a personalized prediction tool for routine management of patients with breast cancer.
Identifiants
pubmed: 32213092
doi: 10.1200/CCI.19.00133
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM